Clinical Trials in China / NCT06783933
Active, not recruiting
Observational
Artificial Intelligence-assisted Diagnosis
NCT06783933 · tracked via the Priya Life Science China tracker
Condition(s) studied
Congenital Heart Disease (CHD)Structural Heart Disease
Investigational drug(s) / intervention(s)
surgical or interventional validation
surgical or interventional validation: surgical or interventional validation
Study summary
This study aims to investigate whether an AI-assisted decision support can improve the diagnosis of congenital heart diseases on Chest X-ray.
Eligibility
Inclusion Criteria:
1. Chest X-ray of patients with ASD;
2. Chest X-ray of patients with VSD;
3. Chest X-ray of patients with PDA;
4. Chest X-ray of patients with PFO;
5. Chest X-ray of patients with PS;
6. Chest X-ray of patients with TOF/PAA;
7. Chest X-ray of patients with MS;
8. Chest X-ray of patients with other heart diseases;
Exclusion Criteria:
1. CHD Patients without surgical, interventional validation;
2. Serious Scoliosis;
3. Pulmonary inflammation or consolidation
Primary outcome measure(s)
- accuracy with AI-assisted diagnosis — 12 months
Number of subjects with accuracy of CHD ; based on surgical validation or interventional validation.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fuwai hospital | Beijing | Beijing Municipality |
More China National Center for Cardiovascular Diseases trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06783933 on ClinicalTrials.gov ↗ ← All trials in China